An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies and Poor Prognoses (I-PREDICT Heme)

Condition:   Hematologic Cancer Intervention:   Drug: Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile Sponsor:   University of California, San Diego Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials